Drug Pipeline

Glycopyrrolate Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
3
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05116930 Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture Post-Dural Puncture Headache Recruiting
NCT05222529 Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide)… Asthma Recruiting
NCT07016412 A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in… Chronic Obstructive Pulmonary Disease Recruiting
Sponsors Running Glycopyrrolate Trials
Mayo Clinic (1) Novartis Pharmaceuticals (1) Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA (1)
Disease Areas
Asthma (1) COPD (1)
Get alerts when Glycopyrrolate trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free